Physician profile
Michael Ted Boler
NPI 1023305687
$6,370.15
in general payments reported to CMS, 2019-2025
34 companies · $1,566 in 2025
The $1,566 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $661 · 2020: $419 · 2021: $505 · 2022: $706 · 2023: $1,135 · 2024: $1,377 · 2025: $1,566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,078.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $810.91 | 2023-2025 | Onyx Frontier, Symplicity G3, In.Pact Admiral |
| Merck Sharp & Dohme LLC | $757.40 | 2021-2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $543.28 | 2019-2024 | |
| Abiomed | $516.25 | 2022-2025 | Impella |
| Astrazeneca Pharmaceuticals Lp | $351.72 | 2019-2025 | Wainua, Farxiga, Lokelma |
| E.R. Squibb & Sons, L.L.C. | $339.35 | 2024-2025 | Camzyos, Eliquis |
| W. L. Gore & Associates, INC. | $325.54 | 2024-2025 | Gore Cardioform Septal Occluder, Gore Viabahn Vbx Balloon Expandable Endo |
| Inari Medical, INC. | $300.46 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $280.22 | 2019-2025 | Watchman Flx |
| Thrombolex, INC. | $240.43 | 2025 | Bashir Endovascular Catheter |
| Cook Medical LLC | $226.46 | 2020-2025 | Zilver Ptx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $218.99 | 2021-2023 | Jardiance |
| Amgen INC. | $193.37 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $191.51 | 2021-2023 | Xience Sierra |
| Lexicon Pharmaceuticals, INC. | $136.18 | 2023-2024 | Inpefa |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $135.00 | 2021-2025 | Nexletol |
| Pfizer INC. | $100.20 | 2020-2025 | |
| Bard Peripheral Vascular, INC. | $96.64 | 2019 | |
| Terumo Medical Corporation | $93.15 | 2022-2024 | Glidewire |
| Janssen Scientific Affairs, LLC | $79.96 | 2019 | |
| Gilead Sciences, INC. | $77.26 | 2019 | |
| Medtronic Vascular, INC. | $73.21 | 2019 | |
| Astellas Pharma US INC | $67.45 | 2019 | |
| Alnylam Pharmaceuticals INC. | $58.17 | 2022-2024 | Onpattro, Amvuttra |
| Scpharmaceuticals INC. | $26.46 | 2025 | |
| Cardiva Medical, INC. | $21.62 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Bayer Healthcare Pharmaceuticals INC. | $19.97 | 2024 | |
| Celonova Biosciences, INC. | $17.47 | 2020 | |
| Novo Nordisk INC | $16.85 | 2025 | Wegovy |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.31 | 2021 | |
| Akcea Therapeutics, INC. | $11.95 | 2019 | |
| Lantheus Medical Imaging, INC. | $11.36 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $3.05 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Boler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.